Industry News Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray by Global Biodefense Staff November 9, 2021
Industry News Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants by Global Biodefense Staff October 27, 2021
Industry News Tonix Pharmaceuticals Opens Infectious Disease R&D Center in Maryland by Global Biodefense Staff October 18, 2021
Industry News GeoVax Receives Patent for VLP Ebola Vaccine by Global Biodefense Staff October 14, 2021
Biodetection PerkinElmer Receives FDA Emergency Use Authorization for Combination COVID/Flu/RSV Test by Global Biodefense Staff October 7, 2021
Industry News Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes by Global Biodefense Staff October 6, 2021
Biodetection FDA Authorizes Flowflex COVID-19 Home Test from ACON Laboratories by Global Biodefense Staff October 4, 2021
Industry News Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA by Global Biodefense Staff October 3, 2021
Industry News Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates by Global Biodefense Staff September 28, 2021
Biodetection HHS Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2 by Global Biodefense Staff September 23, 2021
Biodetection LexaGene Enters into CRADA with DoD to Foster Biothreat Detection Capabilities by Global Biodefense Staff September 23, 2021
Industry News HHS Awards $2.9B to Regeneron for COVID-19 Therapy by Global Biodefense Staff September 14, 2021
Industry News Navrogen Enters CRADA with USAMRIID to Test Small Molecule NK Cell Activators Against SARS-COV-2 Infection by Global Biodefense Staff September 13, 2021
Industry News New Manufacturing Plant Gives Canada Domestic Production Capability for N95-Type Mask Filters by Global Biodefense Staff July 4, 2021
Biodetection UC Davis and SpectraPass Partner on Rapid Mass Spec COVID-19 Test by Global Biodefense Staff April 26, 2021
Industry News University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals by Global Biodefense Staff April 15, 2021
Industry News OSU’s New Vaccine Candidate for COVID-19 Capitalizes on Measles Vaccine’s Successful History by Global Biodefense Staff March 16, 2021
Industry News DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators by Global Biodefense Staff March 2, 2021
Industry News Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses by Global Biodefense Staff February 19, 2021
Industry News BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic by Global Biodefense Staff February 19, 2021
